Akihide Yoshimi

Researcher Name Resolver ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Leukemia

Nature communications

Cancer science

Cancer discovery

National Cancer Centre

Graduate School of Medicine, The University of Tokyo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Centre Jul 01 2020

Japan

Independent Unit Leader :: Cancer RNA Research Unit

Memorial Sloan Kettering Cancer Center Aug 01 2018 - Jun 30 2020

United States

Senior Research Scientist :: Human Oncology and Pathogenesis Program

Memorial Sloan Kettering Cancer Center Aug 01 2015 - Jul 31 2018

United States

Visiting Investigator :: Human Oncology and Pathogenesis Program

The University of Tokyo Apr 01 2011 - May 31 2015

Japan

Project Assistant Professor/Assistant Professor :: Department of Hematology and Oncology

Education History

Graduate School of Medicine, The University of Tokyo Apr 01 2007 - Mar 31 2011

Japan

PHD :: Department of Hematology and Oncology

Publications

Satoshi Kaito, Kazumasa Aoyama, Motohiko Oshima, Akiho Tsuchiya, Makiko Miyota, Masayuki Yamashita, Shuhei Koide, Yaeko Nakajima-Takagi, Hiroko Kozuka-Hata, Masaaki Oyama, Takao Yogo, Tomohiro Yabushita, Ryoji Ito, Masaya Ueno, Atsushi Hirao, Kaoru Tohyama, Chao Li, Kimihito Cojin Kawabata, Kiyoshi Yamaguchi, Yoichi Furukawa, Hidetaka Kosako, Akihide Yoshimi, Susumu Goyama, Yasuhito Nannya, Seishi Ogawa, Karl Agger, Kristian Helin, Satoshi Yamazaki, Haruhiko Koseki, Kazuteru Ohashi, Yuka Harada, Hironori Harada, Atsuya Nishiyama, Makoto Nakanishi, Atsushi Iwama
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization. Nature communications 15 (1) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Kazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, Mitsuaki Ishida, Kensuke Hirosuna, Ryoichi Maenosono, Masahiko Ajiro, Moritoshi Sakamoto, Kengo Iwatsuki, Yuki Nakajima, Takuya Tsujino, Kohei Taniguchi, Tomohito Tanaka, Teruo Inamoto, Yoshinobu Hirose, Fumihito Ono, Yoichi Kondo, Akihide Yoshimi, Haruhito Azuma
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma. NPJ precision oncology 8 (1) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia (2024)
Satoshi Kaito, Kazumasa Aoyama, Motohiko Oshima, Akiho Tsuchiya, Makiko Miyota, Masayuki Yamashita, Shuhei Koide, Yaeko Nakajima-Takagi, Hiroko Kozuka-Hata, Masaaki Oyama, Takao Yogo, Tomohiro Yabushita, Ryoji Ito, Masaya Ueno, Atsushi Hirao, Kaoru Tohyama, Chao Li, Kimihito Cojin Kawabata, Kiyoshi Yamaguchi, Yoichi Furukawa, Hidetaka Kosako, Akihide Yoshimi, Susumu Goyama, Yasuhito Nannya, Seishi Ogawa, Karl Agger, Kristian Helin, Satoshi Yamazaki, Haruhiko Koseki, Kazuteru Ohashi, Yuka Harada, Hironori Harada, Atsuya Nishiyama, Makoto Nakanishi, Atsushi Iwama
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization. Nature communications 15 (1) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Kazumasa Komura, Satoshi Tokushige, Mitsuaki Ishida, Kensuke Hirosuna, Shogo Yamazaki, Kazuki Nishimura, Masahiko Ajiro, Takaya Ohno, Keita Nakamori, Shoko Kinoshita, Takuya Tsujino, Ryoichi Maenosono, Yuki Yoshikawa, Tomoaki Takai, Takeshi Tsutsumi, Kohei Taniguchi, Tomohito Tanaka, Kiyoshi Takahara, Teruo Inamoto, Yoshinobu Hirose, Fumihito Ono, Yuichi Shiraishi, Akihide Yoshimi, Haruhito Azuma
Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab. Cancer science (2023)
Taichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, Kimiyoshi Yano, Akifumi Mochizuki, Makoto Nishino, Tatsuya Yoshida, Yukihiro Yoshida, Nobuhiko Takamatsu, Akihide Yoshimi, Kouya Shiraishi, Hidehito Horinouchi, Takashi Kohno, Ryuji Hamamoto, Jun Adachi, Lee Zou, Bunsyo Shiotani
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. Nature communications 14 (1) (2023)
Yuichi Shiraishi, Ai Okada, Kenichi Chiba, Asuka Kawachi, Ikuko Omori, Raúl Nicolás Mateos, Naoko Iida, Hirofumi Yamauchi, Kenjiro Kosaki, Akihide Yoshimi
Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data. Nature communications 13 (1) (2022)
Yu Hai, Asuka Kawachi, Xiaodong He, Akihide Yoshimi
Pathogenic Roles of RNA-Binding Proteins in Sarcomas. Cancers 14 (15) (2022)
Hirofumi Yamauchi, Kazuki Nishimura, Akihide Yoshimi
Aberrant RNA splicing and therapeutic opportunities in cancers. Cancer science (2021)
Steven De Munck, Mathias Provost, Michiko Kurikawa, Ikuko Omori, Junko Mukohyama, Jan Felix, Yehudi Bloch, Omar Abdel-Wahab, J Fernando Bazan, Akihide Yoshimi, Savvas N Savvides
Structural basis of cytokine-mediated activation of ALK family receptors. Nature 600 (7887) (2021)
Zhaoqi Liu, Akihide Yoshimi, Ji-Guang Wang, Hana Cho, Stanley Chun-Wei Lee, Michelle Ki, Lillian Bitner, Timothy Chu, Harshal Shah, Bo Liu, Anthony R Mato, Peter Ruvolo, Giulia Fabbri, Laura Pasqualucci, Omar Abdel-Wahab, Raul Rabadan
Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization. Cancer discovery 10 (6) (2020)
Kensuke Takaoka, Masahito Kawazu, Junji Koya, Akihide Yoshimi, Yosuke Masamoto, Hiroaki Maki, Takashi Toya, Takashi Kobayashi, Yasuhito Nannya, Shunya Arai, Toshihide Ueno, Hironori Ueno, Kenshi Suzuki, Hironori Harada, Atsushi Manabe, Yasuhide Hayashi, Hiroyuki Mano, Mineo Kurokawa
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination. Leukemia 33 (7) (2019)
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer L Picarsic, David Abramson, Veronica Rotemberg, Steven De Munck, Erwin Pannecoucke, Sydney X Lu, Alessandro Pastore, Akihide Yoshimi, Diana Mandelker, Ozge Ceyhan-Birsoy, Gary A Ulaner, Michael Walsh, Mariko Yabe, Kseniya Petrova-Drus, Maria E Arcila, Marc Ladanyi, David B Solit, Michael F Berger, David M Hyman, Mario E Lacouture, Caroline Erickson, Ruth Saganty, Michelle Ki, Ira J Dunkel, Vicente Santa-María López, Jaume Catala-Mora, Julien Haroche, Jean François Emile, Olivier Decaux, Frederic Geissmann, Savvas N Savvides, Alexander E Drilon, Eli L Diamond, Omar Abdel-Wahab
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nature medicine 25 (12) (2019)
Justin Taylor, Maria Sendino, Alexander N Gorelick, Alessandro Pastore, Matthew T Chang, Alexander V Penson, Elena I Gavrila, Connor Stewart, Ella M Melnik, Florisela Herrejon Chavez, Lillian Bitner, Akihide Yoshimi, Stanley Chun-Wei Lee, Daichi Inoue, Bo Liu, Xiao J Zhang, Anthony R Mato, Ahmet Dogan, Michael Gregory Kharas, Yuhong Chen, Demin Wang, Rajesh K Soni, Ronald C Hendrickson, Gorka Prieto, Jose A Rodriguez, Omar Abdel-Wahab
Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis. Cancer discovery 9 (10) (2019)

Akihide Yoshimi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Akihide Yoshimi